The Complex Connection between Cannabis and Schizophrenia

The Complex Connection between Cannabis and Schizophrenia provides an in-depth overview of the current state of research into the role that cannabis plays in schizophrenia, covering both the pathophysiological and the pharmacological implications. It addresses the epidemiology of cannabis use and the risks associated with its use, the biological aspects of the drug, its effects on the brain and the pharmacological possibilities of using cannabidiol to treat schizophrenia.

It is the only book on the market devoted exclusively to examining the links between this very commonly used (and misused) drug and a specific set of devastating psychiatric illnesses, providing a comprehensive guide to our current understandings of this relationship.

Marijuana is the most commonly used illicit drug globally, and is becoming increasingly decriminalized and even legalized worldwide. Among the numerous mental-health concerns related to the drug, there is mounting evidence of an intricate link between cannabis use and schizophrenia and related psychotic disorders. At the same time, there is promising evidence to suggest that cannabidiol, one of the many compounds found in cannabis that activates the brain's cannabinoid receptors, could prove to be an effective antipsychotic to treat schizophrenia.

Autorentext
Professor of Clinical Psychiatry, Columbia University College of Physicians and Surgeons, NY, USA Clinical Assistant Professor of Psychiatry, New York University School of Medicine, NY USA

Klappentext
The Complex Connection between Cannabis and Schizophrenia provides an in-depth overview of the current state of research into the role that cannabis plays in schizophrenia, covering both the pathophysiological and the pharmacological implications. It addresses the epidemiology of cannabis use and the risks associated with its use, the biological aspects of the drug, its effects on the brain and the pharmacological possibilities of using cannabidiol to treat schizophrenia.

It is the only book on the market devoted exclusively to examining the links between this very commonly used (and misused) drug and a specific set of devastating psychiatric illnesses, providing a comprehensive guide to our current understandings of this relationship.

Marijuana is the most commonly used illicit drug globally, and is becoming increasingly decriminalized and even legalized worldwide. Among the numerous mental-health concerns related to the drug, there is mounting evidence of an intricate link between cannabis use and schizophrenia and related psychotic disorders. At the same time, there is promising evidence to suggest that cannabidiol, one of the many compounds found in cannabis that activates the brain's cannabinoid receptors, could prove to be an effective antipsychotic to treat schizophrenia.

Inhalt

1. Introduction to the Complex Connection between Cannabis Use and Psychosis, Psychotic Disorders, and Schizophrenia
   *Marc W. Manseau and Michael T. Compton
   
   2. The Epidemiology of Cannabis Use in the United States
   Wilson M. Compton and Beth Han
   
   3. The Biology of Cannabis in the Brain, and the Endocannabinoid System
   David Louis Atkinson and Jeff. K. Abbott
   
   4. Psychotomimetic and Cognitive Effects of 9-Tetrahydrocannabinol in Laboratory Settings
   John D. Cahill, Swapnil Gupta, Jose Cortes-Briones, Rajiv Radhakrishnan, Mohamed Sherif, Deepak C. D'Souza
   
   5. Psychotomimetic and Cognitive Effects of Cannabis Use in the General Population
   Nadia Solowij
   
   6. Effects of Cannabis Use among those with Schizotypy
   Angelo B. Cedeno
   
   7. Effects of Cannabis Use among those at Clinical High Risk for Schizophrenia
   Brian O'Donoghue, Meredith McHugh, Barnaby Nelson, and Patrick McGorry
   
   8. Cannabis-Induced Psychotic Disorders
   Luca Pauselli
   
   9. Synthetic Cannabinoids and Synthetic Cannabinoid-Induced Psychotic Disorders
   Papanti Duccio, Schifano Fabrizio, and Orsolini Laura
   
   10. Cannabis Use as an Independent Risk Factor for, or Component Cause of, Schizophrenia and Related Psychotic Disorders
   Jodi M. Gilman, Sara M. Sobolewski, and Anne Eden Evins
   
   11. Cannabis Use as a Determinant of Earlier Age at Onset of Schizophrenia and Related Psychotic Disorders
   Claire Ransay Wan and Beth Broussard
   
   12. The Prevalence of Cannabis Use, and Effects on Course and Outcomes, among Individuals with Schizophrenia and Related Psychotic Disorders
   
   *Ana Fresán, Rebeca Robles-García, and Carlos-Alfonso Tovilla-Zarate
   
   13. The Treatment of Cannabis Use Disorders among Individuals with Psychotic Disorders
   Peter Bosanac, Ana Lusicic, and David J. Castle
   
   14. Cannabidiol as a Potential Novel Therapeutic Agent for Psychotic Disorders
   Serena Deiana and Erica Zamberletti *